Coronary stent technology: a narrative review

• Prince of Wales Hospital, Sydney, NSW

---

• 1. Chen D, Jepson N. Coronary stent technology: a narrative review. Med J Aust 2016; 205: 277-281. <MJA full text>
• 2. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-638.
• 3. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541-2619.
• 4. Sipahi I, Akay MH, Dagdelen S, et al. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials on the arterial grafting and stent era. JAMA Intern Med 2014; 174: 223-230.
• 5. Park SJ, Ahn JM, Kim YH, et al. Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 2015; 372: 1204-1212.
• 6. Cockburn J, Hildick-Smith D, Trivedi U, de Belder A. Coronary revascularisation in the elderly. Heart 2017; 103: 316-324.
• 7. Kappetein A, Serruys P, Sabik J, et al. Design and rationale for a randomised comparison of everolimus-eluting stents and coronary bypass graft surgery in selected patients with left main coronary disease: the EXCEL trial. Eurointervention 2016; 12: 861-872.